scholarly article | Q13442814 |
P50 | author | Noga Givon-Lavi | Q47460873 |
Ron Dagan | Q92965709 | ||
P2093 | author name string | David Greenberg | |
Yair Sadaka | |||
Noga Givon-Lavi | |||
Jacob Bar-Ziv | |||
Shalom Ben-Shimol | |||
P433 | issue | 2 | |
P921 | main subject | placebo | Q269829 |
alveolar pneumonia | Q11611666 | ||
pneumonia | Q12192 | ||
P304 | page(s) | 136-142 | |
P577 | publication date | 2014-02-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial | |
P478 | volume | 33 |
Q38867802 | A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR. |
Q38628311 | An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence |
Q89945831 | Antibiotic Prescribing Patterns for Acute Otitis Media for Children 2 Years and Older |
Q90370905 | Antibiotic Use and Outcomes in Children in the Emergency Department With Suspected Pneumonia |
Q42339223 | Antibiotics in childhood pneumonia: how long is long enough? |
Q57153846 | Antimicrobial Therapy in Community-Acquired Pneumonia in Children |
Q33642866 | Antimicrobial stewardship in daily practice: Managing an important resource |
Q85911781 | Antimicrobial stewardship in daily practice: Managing an important resource |
Q94587430 | Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission |
Q40041892 | Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. |
Q90096269 | Community-acquired pneumonia among children: the latest evidence for an updated management |
Q36070209 | Comparative Effectiveness of Beta-lactam Versus Macrolide Monotherapy in Children with Pneumonia Diagnosed in the Outpatient Setting |
Q33792393 | Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines |
Q33678141 | Discovery and validation of biomarkers to guide clinical management of pneumonia in African children |
Q64899765 | Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT). |
Q64092119 | HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial |
Q37220711 | Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America |
Q55619166 | La gestion des antimicrobiens dans la pratique quotidienne : administrer une ressource importante. |
Q46486735 | La pneumonie non compliquée chez les enfants et les adolescents canadiens en santé : points de pratique sur la prise en charge |
Q38767450 | Recent Developments in Pediatric Community-Acquired Pneumonia. |
Q47547063 | Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial |
Q24187150 | Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months |
Q41986988 | Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. |
Q36425466 | Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management. |
Q40488754 | Variation in paediatric hospital antibiotic guidelines in Europe. |
Search more.